Latvia vs United States: Proportion of the target population who received the final dose
Latvia
51.0%
in 2024
United States
52.0%
in 2024
Latvia rank
73rd
United States rank
71st
Proportion of the target population who received the final dose over time
- Latvia
- United States
How they compare
United States currently reports 52.0% against 51.0% in Latvia, a difference of 1.0%.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Latvia ahead.
Latvia ranks 73rd and United States ranks 71st of 108 countries.
Across the 2 decades both report, Latvia averaged higher in 1 and United States in 1.
Head to head by decade
| Decade | Latvia | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.1% | 32.6% | 9.6% | Latvia |
| 2020s | 43.6% | 50.8% | 7.2% | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Latvia or United States?
- United States, at 52.0% against 51.0% in Latvia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Latvia and United States?
- 1.0%, with United States ahead.
- How many years of comparable data are there for Latvia and United States?
- 14 years are reported by both, from 2011 to 2024.
- How do Latvia and United States rank globally for proportion of the target population who received the final dose of?
- Latvia ranks 73rd and United States ranks 71st of 108 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.